Skip to content
Search

Latest Stories

UK competition watchdog to investigate PCR Covid test price

The UK’s competition watchdog said on Thursday (August 12) it would investigate the price of PCR Covid tests ‘immediately’ and help the government in taking action against testing companies if they were found breaching consumer law.

Health Secretary Sajid Javid had written to the Competition and Markets Authority (CMA) on August 6 asking it to look into the market for PCR tests to ensure that consumers did not face unnecessarily high charges or poor service.


The CMA said in a statement that it was exploring if individual PCR providers were breaching their obligations under consumer law, and if there were structural problems in the market for PCR tests that could affect price or reliability.

It would also examine if there was any immediate action that the government could take in the meantime.

George Lusty, CMA Senior Director for Consumer Protection, said: “It is essential that people paying for PCR tests are treated fairly, get what they pay for and that their rights are respected when things go wrong. We will not hesitate to take enforcement action if we find evidence that PCR providers are breaching consumer law.

“We are also working closely with DHSC to get the data we need to identify the cause of any wider problems in the PCR testing market, and to ground our advice on what action may be needed.”

For international travel during the coronavirus pandemic, the UK has divided countries in three categories, with low-risk countries rated green for quarantine-free travel, medium risk countries rated amber, and red countries requiring arrivals to spend 10 days in isolation in a hotel.

Tests cost about £75 per person on average but there are reports of some being offered for as little as £20, and others more than £500.

All travellers from countries on the green and amber lists must book a test to be taken two days after they arrive in Britain.

Earlier, the CMA had said it would respond to Javid’s request “within a month”, which sparked an angry reaction from travel industry and people.

“...we welcome the opportunity to explore issues in the PCR testing market in more depth. We recognise that this is a very live issue, impacting consumer now, so we will tailor our work to allow us to respond within the next month,” CMA Chief Executive Andrea Coscelli CBE said in a letter addressed to the Health Secretary Sajid Javid on August 10.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less